Co-regulated expression of glomerular 12/15-lipoxygenase and interleukin-4 mRNAs in rat nephrotoxic nephritis.
about
Effects of mutant p53 expression on human 15-lipoxygenase-promoter activity and murine 12/15-lipoxygenase gene expression: evidence that 15-lipoxygenase is a mutator geneResolution of inflammation: a new paradigm for the pathogenesis of periodontal diseasesEffect of IL-4 on altered expression of complement activation regulators in rat pancreatic cells during severe acute pancreatitisRegulation of leukocyte trafficking by lipoxins.Products of 12/15-lipoxygenase upregulate the angiotensin II receptor.Lipoxins as biomarkers of lupus and other inflammatory conditionsRegulated spatial distribution of cyclooxygenases and lipoxygenases in Crohn's ulcer.Current and emerging strategies for the treatment and management of systemic lupus erythematosus based on molecular signatures of acute and chronic inflammationInflammatory bowel disease as a disorder of an imbalance between pro- and anti-inflammatory molecules and deficiency of resolution bioactive lipids.Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis.Effects of cholesterol-tagged small interfering RNAs targeting 12/15-lipoxygenase on parameters of diabetic nephropathy in a mouse model of type 1 diabetesThe role of mid-chain hydroxyeicosatetraenoic acids in the pathogenesis of hypertension and cardiac hypertrophy.Diabetic macular edema, retinopathy and age-related macular degeneration as inflammatory conditionsIs There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?The oxidized lipid and lipoxygenase product 12(S)-hydroxyeicosatetraenoic acid induces hypertrophy and fibronectin transcription in vascular smooth muscle cells via p38 MAPK and cAMP response element-binding protein activation. Mediation of angiotenLipoxins, resolvins, protectins, maresins and nitrolipids, and their clinical implications with specific reference to diabetes mellitus and other diseases: part II
P2860
Q22009375-0CB73526-608E-4AD0-BC6B-948564B6BD28Q28206660-05117F60-FC1B-4734-95A4-2EFDAA70E1B9Q28580630-703C0FB3-0E7C-44CB-802A-8082A7C2157EQ33649861-1DDAD9D7-2690-4A26-B990-C05A1CEAA009Q34743589-E5EC368F-5AA3-4B28-BD6B-CD057C3E9694Q35044584-65D747A2-C07E-4B83-B369-7446DCF42BE8Q35070568-65344C56-7894-4D2D-9546-B81FFF6198FEQ35557372-8C2B67D4-1213-4D8C-8080-5BC2969A4AE6Q36461242-EBB85C23-5A57-41BA-BBC0-9EEA4CDF5B16Q36674181-643A0A22-2827-4901-8905-68352230E6B0Q36844506-1A74BA66-A828-4B65-9167-5AB12ACB72F8Q38622658-C8A74D8D-BD3C-404C-BEA7-0DD5C41DD92FQ41049002-BC5EA35C-B18F-49E2-9BD2-4466D1B2E909Q41205365-98B8CB25-FE32-45E8-A4D9-D99B8B6097B7Q42515569-47F0C8A1-26E9-4488-BD64-68AACB0BF5FDQ56699408-1E7DF20B-0FA1-4725-9FD3-A209C5AB33DB
P2860
Co-regulated expression of glomerular 12/15-lipoxygenase and interleukin-4 mRNAs in rat nephrotoxic nephritis.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Co-regulated expression of glo ...... in rat nephrotoxic nephritis.
@en
Co-regulated expression of glo ...... in rat nephrotoxic nephritis.
@nl
type
label
Co-regulated expression of glo ...... in rat nephrotoxic nephritis.
@en
Co-regulated expression of glo ...... in rat nephrotoxic nephritis.
@nl
prefLabel
Co-regulated expression of glo ...... in rat nephrotoxic nephritis.
@en
Co-regulated expression of glo ...... in rat nephrotoxic nephritis.
@nl
P2093
P356
P1433
P1476
Co-regulated expression of glo ...... in rat nephrotoxic nephritis.
@en
P2093
P2888
P304
P356
10.1038/KI.1994.280
P407
P577
1994-08-01T00:00:00Z